2
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13812 |
PCA50941
|
Others | Others |
PCA50941 is a 1,4-dihydropyridine derivative, treatment for cardiovascular disease. | |||
T16701 |
QCA570
|
Others; PROTACs | Others; PROTAC |
QCA570 is an effective BET degrader based on PROTAC (IC50: 10 nM for BRD4 BD1 Protein). |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-01038 |
CA5A Protein, Human, Recombinant
Carbonic anhydrase VA,Carbonic anhydrase <... |
Human | HEK293 Cells |
Reversible hydration of carbon dioxide. Low activity. CA5A Protein, Human, Recombinant is expressed in HEK293 mammalian cells. The predicted molecular weight is 30.6 kDa and the accession number is P35218. | |||
TMPY-01877 |
CA5A Protein, Human, Recombinant (His)
CA5,GS1-21A4.1,CA5AD, |
Human | E. coli |
Carbonic anhydrase 5A, mitochondrial, also known as Carbonate dehydratase VA, Carbonic anhydrase VA, CA-VA and CA5A, is a member of thealpha-carbonic anhydrase family. Carbonic anhydrases (CAs) are a large family of zinc metalloenzymes first discovered in 1933 that catalyze the reversible hydration of carbon dioxide. CAs participate in a variety of biological processes, including respiration, calcification, acid-base balance, bone resorption, and the formation of aqueous humor, cerebrospi... |